Penserra Capital Management LLC Lowers Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Penserra Capital Management LLC cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,296 shares of the exchange traded fund’s stock after selling 1,521 shares during the quarter. Penserra Capital Management LLC owned about 0.05% of SPDR S&P Biotech ETF worth $4,080,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of XBI. BOKF NA raised its holdings in SPDR S&P Biotech ETF by 71.4% in the first quarter. BOKF NA now owns 840 shares of the exchange traded fund’s stock valued at $79,000 after buying an additional 350 shares during the period. B. Riley Wealth Advisors Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 15.2% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 7,071 shares of the exchange traded fund’s stock valued at $671,000 after acquiring an additional 933 shares in the last quarter. Global Financial Private Client LLC purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter worth $793,000. Jane Street Group LLC increased its holdings in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Finally, Castleark Management LLC acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at $9,506,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $96.24 on Monday. SPDR S&P Biotech ETF has a 12 month low of $71.99 and a 12 month high of $105.47. The stock’s 50-day moving average is $98.44 and its two-hundred day moving average is $96.32. The stock has a market cap of $7.34 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.